IDEAYA Biosciences, Inc. (IDYA)
$40.11-$1.66 (-3.97%) Today
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 9,550 | $382K |
| Grant or award | 6 | 120,000 | |
| Option exercise | 2 | 19,100 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
17 Form 4 filings on record, the earliest from Jun 24, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Briseno Andres Ruiz - Officer | Option exercise | Common Stock | 9,550 | $12.86 | $123K | |
| Briseno Andres Ruiz - Officer | Open-market sale | Common Stock | 9,550 | $40.01 | $382K | |
| Briseno Andres Ruiz - Officer | Option exercise | Stock Option (Right to Buy) | 9,550 | $0.00 | - | |
| Wendy L. Yarno | Grant or award | Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Jeffrey Stein | Grant or award | Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Terry J. Rosen | Grant or award | Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Scott W. Morrison | Grant or award | Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Catherine J. Mackey | Grant or award | Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Malcolm Garret Hampton | Grant or award | Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Jeffrey Stein | Open-market purchase | Common Stock | 50,000 | $32.96 | $1.65M | |
| Joshua Bleharski - Officer | Grant or award | Stock Option (right to buy) | 170,000 | $0.00 | - | |
| Michael Anthony White - Officer | Grant or award | Stock Option (right to buy) | 190,000 | $0.00 | - | |
| Darrin Beaupre - Officer | Grant or award | Stock Option (right to buy) | 175,000 | $0.00 | - | |
| Stuart Dorman - Officer | Grant or award | Stock Option (right to buy) | 155,000 | $0.00 | - | |
| Yujiro S. Hata - Officer | Grant or award | Stock Option (right to buy) | 600,000 | $0.00 | - | |
| Douglas B. Snyder - Officer | Grant or award | Common Stock | 1,039 | $16.91 | $18K | |
| Douglas B. Snyder - Officer | Grant or award | Common Stock | 1,041 | $16.91 | $18K | |
| Douglas B. Snyder - Officer | Grant or award | Stock Option (right to buy) | 130,000 | $0.00 | - | |
| Briseno Andres Ruiz - Officer | Grant or award | Common Stock | 682 | $23.26 | $16K | |
| Briseno Andres Ruiz - Officer | Grant or award | Common Stock | 1,253 | $16.91 | $21K | |
| Briseno Andres Ruiz - Officer | Grant or award | Stock Option (right to buy) | 80,000 | $0.00 | - | |
| Wendy L. Yarno | Grant or award | Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Terry J. Rosen | Grant or award | Stock Option (right to buy) | 20,000 | $0.00 | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR |
IDEAYA Biosciences, Inc. (IDYA) had 7 insider filings in the last 90 days, with the most recent on 2026-07-09. The full record for IDYA runs to 17 Form 4 filings, the earliest from 2025-06-24. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of IDYA were filed in the last 90 days. 1 purchase is on record for this company.
1 insider sale of IDYA was filed in the last 90 days, totaling $382K.
This page tracks IDYA Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add IDYA to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
